The agency reported one of the products lacked the assurance of sterility.
The Food and Drug Administration (FDA) issued an announcement this week that four types of eye ointments produced in India by Brassica Pharma are being voluntarily recalled. The recall is the result of the FDA finding a “lack of sterility assurance” at one of the product holding facilities. There have been no reports of eye infections filed due to using one of the identified lubricants, but the FDA has advised patients to stop using them.
“For those patients who use these products, there is a potential risk of eye infections or related harm,” the FDA stated. “Ophthalmic drug products pose a potential heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses.”
The ointments include generic brands from retailers such as CVS and Walmart.
As the Lord Leads, Pray with Us…
- For FDA officials as they seek to ensure the safety of over-the-counter health substances and medications.
- For Commissioner Robert Califf to be led by the Lord as he oversees the FDA.
Sources: The Hill, U.S. News, Food and Drug Administration
